Article: Prasco and Axcan Pharma[TM] Sign a Distribution and Supply Agreement for Authorized Generic Versions of URSO Forte[R] Scored and URSO 250[R] (Ursodiol Tablets, USP).

Article: Teva Announces Approval and Launch of Generic Urso 250[R] and ...
Business Wire;  May 14, 2009 ;     700+ words ... ... Abbreviated New Drug Application (ANDA) for Ursodiol Tablets USP, 250 mg and 500 mg. Teva's Ursodiol Tablets are the AB-rated generic equivalents of Axcan's Urso 250[R] and Urso Forte[R], which are indicated for treatment ...

Article: URSO Forte launched in the U.S.
Biotech Business Week;  December 6, 2004 ;     666 words ... ... Inc., announced the launch of new URSO Forte. This 500 mg ursodiol tablet was recently ... Primary Biliary Cirrhosis (PBC). "URSO Forte will help improve compliance, simplify ... transplantation in these patients," Lindor said. URSO Forte, and its lower dose equivalent, URSO ...

Article: Axcan Launches URSO Forte(TM) in the U.S.
PR Newswire;  November 2, 2004 ;     700+ words ... ... announced today the launch of new URSO Forte(TM). This unique, 500 mg ursodiol ... Primary Biliary Cirrhosis (PBC). "URSO Forte(TM) will help improve compliance ... transplantation in these patients." URSO Forte(TM), and its lower dose equivalent ...

Article: Prasco offers praise for FTC report.(RX RETAIL PHARMACY: Generic ...
Chain Drug Review;  July 20, 2009 ;     700+ words ... ... of the URSO 250 and URSO Forte Scored (ursodiol tablets, USP) family of products ... the brand product." Ursodiol tablets, 500 mg, and Ursodiol tablets, 250 mg, are AB ... substitutable for the brand URSO Forte Scored and URSO 250 ...

Article: Axcan Goes Private Through $1.3B TPG Acquisition Deal.
BIOWORLD Today;  November 30, 2007 ;     700+ words ... ... of gastrointestinal products marketed in the U.S. and Europe, but the strongest performers were URSO Forte and URSO 250 (ursodiol tablets) for primary biliary cirrhosis, with $77 million in U.S. sales; Canasa (mesalamine) for active ...

Article: Axcan Reports Results For First Quarter of 2003 - Revenue Up 33% ...
PR Newswire;  February 6, 2003 ;     700+ words ... ... product line from Abbott Laboratories. Also, at the end of the quarter, the Company also acquired DELURSAN (250 mg ursodiol tablets) from Aventis Pharma S.A. These acquisitions, that were both accretive and strategic, will allow Axcan to expand ...

Article: Annual General Meeting of Shareholders - Following major ...
PR Newswire;  February 19, 2004 ;     700+ words ... ... fiscal 2004. URSO DS. Axcan filed a Supplemental New Drug Application in the United States for URSO DS (500 milligram ursodiol tablets) for the treatment of Primary Biliary Cirrhosis. Approval is expected during fiscal 2004. Phase III studies ...